This document discusses hypo and hypermagnesemia, detailing the body's magnesium stores, mechanisms of absorption, causes, clinical presentation, and management strategies for magnesium disorders. Hypomagnesemia is characterized by low serum magnesium levels and can occur due to various factors including dietary deficiencies and certain medical conditions, while hypermagnesemia is often related to renal failure or excessive intake. Guidelines for treatment include dietary interventions, oral or intravenous supplementation, and monitoring for complications like hypocalcemia or cardiac issues.
The total bodystores of magnesium are between 21 and 28 g in
the average 70 kg adult.
Normal serum magnesium usually has a range of 1.7 to 2.5 mg/dL.
Most of the body's magnesium is in the skeletal bone mass, which
accounts for more than 50% of the body's stores.
The remainder is located in soft tissue, of which only 1% is located
extracellularly.
INTRODUCTION
3.
• 60% ofMg exists as physiologically active ionised form
• 30% is protein bound mainly to albumin
• remaining 10 % forms complexes with plasma anions such as
phosphates and citrates
IN PLASMA
4.
• About 30-40%of dietary magnesium (140– 360 mg/d) is
absorbed, principally in the jejunum and ileum.
• Magnesium excretion in urine usually matches net intestinal
absorption (100 mg/d).
• Serum magnesium concentration is regulated by renal
magnesium reabsorption.
• Parathyroid hormone increases magnesium reabsorption in the
cTAL, whereas hypercalcemia and hypermagnesemia inhibit
magnesium reabsorption.
METABOLISM
5.
RENAL HANDLING
About 60%of magnesium is reabsorbed in the cortical thick
ascending limb of loop of Henle (cTAL), whereas 20% of filtered
magnesium is reabsorbed in the proximal tubule, and another 5–
10% in the distal convoluted tubule.
PROXIMAL TUBULE
Mg absorption in the proximal tubule is dependant on the filtered
load as well as net salt and water reabsorption.
6.
THICK ASCENDING LOOP
Paracellular Mg transport is driven by a favorable lumen positive
electrochemical gradient which is generated by a transcellular
reabsorption of NaCl
It is dependant on the activity of Na+-k & -cl co-transporter, renal
outer medullary channel, Na+-k +-ATPase pump and renal Cl-
channel
Claudins are the major components of tight junction strands in the
TAL, where the reabsorption of magnesium occurs
7.
DISTAL CONOLUTED TUBULES
Thetransport rate in this segment defines the final urinary Mg+
concentration as no reabsorption takes place beyond this level
The cells in this nephron segment have highest energy consumption
of the nephrons
Na+-cl- cotransporter, which is exclusively present in the DCT is
important for active reabsorption of Mg Approx 3% of filtered Mg
is excreted in the urine
WHAT IS IT??
Hypomagnesemiais an electrolyte disturbance in which there is
an abnormally low level of magnesium in the blood.
Hypomagnesemia is not necessarily magnesium deficiency.
Hypomagnesemia can be present without magnesium deficiency
and vice versa.
10.
CAUSES
Related to decreasedMg intake
• Starvation
• Alcohol dependence
• Total parenteral nutrition II. Related
to redistribution of Mg from ECF to ICF
• Hungry bone syndrome
• Treatment of diabetic ketoacidosis
• Alcohol withdrawal syndromes
• Acute pancreatitis
11.
Related to GIMg loss
•Diarrhea
•Vomiting and nasogastric suction
•Gastrointestinal fistulas.
•Hypomagnesemia with secondary hypocalcemia (HSH)
12.
• Diuretics -Loop diuretics, osmotic diuretics, and chronic use of
thiazides
• Antimicrobials - Amphotericin B, aminoglycosides, pentamidine,
capreomycin, viomycin, and foscarnet
• Chemotherapeutic agents - Cisplatin
• Immunosuppressants - Tacrolimus and cyclosporine
• Proton-pump inhibitors
• Ethanol
DRUGS
13.
REDISTRIBUTION FROM ICFTO
ECF
Hungry bone syndrome, in which magnesium is removed
from the extracellular fluid space and deposited in bone following
parathyroidectomy or total thyroidectomy or any similar states of
massive mineralization of the bones
Hypomagnesemia may also occur following insulin therapy for
diabetic ketoacidosis and may be related to the anabolic effects of
insulin driving magnesium, along with potassium and phosphorus,
back into cells.
14.
The risk ofhypomagnesemia can be summarized as follows:
• 2% in the general population
• 10-20% in hospitalized patients
• 50-60% in intensive care unit (ICU)
patients
• 30-80% in persons with alcoholism
• 25% in outpatients with diabetes
15.
CLINICAL PRESENTATION
A carefulfamily history is important, particularly when acquired
causes of hypomagnesemia have to be excluded
Often associated with multiple biochemical abnormalities, including
hypokalemia, hypocalcemia, and metabolic acidosis.
As a result, hypomagnesemia is sometimes difficult to attribute
solely to specific clinical manifestations
16.
RELATED METABOLIC
CONDITIONS
Hypokalemia isa common event in patients with
hypomagnesemia, occurring in 40-60% of cases
Partly due to underlying disorders that cause magnesium and
potassium losses, including diuretic therapy and diarrhoea
The mechanism for hypomagnesemia-induced hypokalemia
relates to the intrinsic biophysical properties of renal outer
medullary K+ (ROMK) channels mediating K+ secretion in the TAL
and the distal nephron.
17.
The classic signof severe hypomagnesemia (< 1.2 mg/dL) is hypocalcemia.
The mechanism is multifactorial.
• Impaired magnesium-dependent adenylcyclase mediates the
decreased release of PTH causing hypocalcemia.
• Skeletal resistance to this hormone in magnesium deficiency has
also been implicated.
• Hypomagnesemia also alters the normal hetero-ionic exchange of
calcium and magnesium at the bone surface, leading to an
increased bone release of magnesium ions in exchange for an
increased skeletal uptake of calcium from the serum.
18.
EFFECT ON CVS
Thecardiovascular effects of magnesium deficiency include effects
on electrical activity, myocardial contractility, potentiation of digitalis
effects, and vascular tone
Hypomagnesemia is also recognized to cause cardiac arrhythmia
like Monomorphic ventricular tachycardia, Torsade de pointes,
Ventricular fibrillation.
Changes in ECG are non
specific like prolongation
of conduction and slight
ST depression,
Nonspecific T-wave
changes, U waves may b
seen, Prolonged QT seen
19.
NEUROMUSCULAR
MANIFESTATION
The earliest manifestationsof magnesium deficiency are usually
neuromuscular and neuropsychiatric disturbances, the most
common being hyper excitability.
Neuromuscular irritability, including tremor, fasciculation's, tetany,
Chvostek and Trousseau signs, and convulsions, may be present.
Other manifestations include Apathy, Muscle cramps, Hyper-
reflexia, Acute organic brain syndromes, Depression, Generalized
weakness, Anorexia, Vomiting
A surrogate fordirect intracellular magnesium is the measurement of
magnesium retention after acute magnesium loading
An infused magnesium load - 2.4 mg/kg of lean body weight over the
initial 4 h is given
A magnesium deficiency is indicated if a patient has reduced
excretion (< 80% over 24 h)
Patients with malnutrition, cirrhosis, diarrhea, or long-term diuretic
use typically have a positive test, whether or not they have signs or
symptoms referable to magnesium depletion.
GOLD STANDARD
22.
MANAGEMENT
Diet- The normalrecommended daily allowance of Mg is 420 mg for
men and 320 mg for women
Green vegetables such as spinach are good sources of magnesium
(which is contained in the chlorophyll molecule)
Some legumes (beans and peas), nuts and seeds, and whole,
unrefined grains are also good sources of magnesium
Hypokalemia,hypocalcemia,andhypophosphatemiaareoftenpresent
withseverehypomagnesemiaandmustbe monitoredcarefully. Hypocalcemia
Doesnot developuntil[Mg]fallsbelow1.2 milligrams/dL.
23.
oral replacement shouldbe given in the asymptomatic patient,
preferably with a sustained-release preparation
Bioavailability of oral preparations is assumed to be 33% in the
absence of intestinal malabsorption
• Mag-Ox 400, containing magnesium oxide
• Slow-Mag, containing magnesium chloride
• Mag-Tab, containing magnesium lactate
These preparations provide about 60 – 84 mg of Mg per tablet
500mg of magnesium gluconate contain 27 mg of elemental
magnesium & 1gm of magnesium sulfate contains 98 mg of
elemental magnesium
24.
The hypocalcemic-hypomagnesemic patientwith tetany or the
patient who is suspected of having hypomagnesemic-hypokalemic
ventricular arrhythmias are given 50 mEq of intravenous
magnesium, given slowly over 8-24 hours
This dose can be repeated as necessary to maintain the plasma
magnesium concentration above 1.0
Non emergency cases 64 mEq in first 24 hrs and 32 mEq daily for
2 to 6 days, should be continued for 1 – 2 days after serum Mg
level normalises
25.
ADVERSE EFFECT
The mainadverse effect of Mg replacement is hypermagnesemia
due to administration at an excessive rate or excessive amount
Side effect include facial flushing, loss of deep tendon reflex,
hypotension, AV block May precipitate tetany as well in cases of
hypocalcemia by increasing urinary calcium excretion
antidotes for hypermagnesemia is Intravenous calcium chloride or
gluconate (1-2 ampules should be administered immediately )
Hypermagnesemia is rarelyencountered in emergency medicine
practice, because the kidney can Increase the fractional excretion of
Mg up to nearly 100%. A small elevation in serum concentration has
little clinical significance.
The most common cause for hypermagnesemia can be found in
patients with renal insufficiency or renal failure who ingest Mg2+ -
containing drugs.
Hypermagnesemia is more commonly seen in the perinatal setting
secondary to the treatment of preeclampsia or eclampsia.
28.
CAUSES
The most commoncause of hypermagnesemia is renal failure.
Other causes include the following:
• Excessive intake(Antacids, Laxatives)
• Lithium therapy
• Hypothyroidism
• Addison disease
• Familial hypocalciuric hypercalcemia
• Milk alkali syndrome
• Depression
29.
SYMPTOMS
Plasma magnesium concentration4 to 6 mEq/L (4.8 to 7.2 mg/dL
or 2 to 3 mmol/L) – nausea, flushing, headache, lethargy,
drowsiness, and diminished deep tendon reflexes.
Plasma magnesium concentration 6 to 10 mEq/L (7.2 to 12 mg/dL
or 3 to 5 mmol/L) – somnolence, hypocalcemia, absent deep
tendon reflexes, hypotension, Bradycardia, and ECG changes.
30.
Plasma magnesium concentrationabove 10 mEq/L (12 mg/dL or 5
mmol/L) – muscle paralysis, respiratory paralysis, complete heart
block, and cardiac arrest. In most cases, respiratory failure
precedes cardiac collapse.
31.
Magnesium is aneffective calcium channel blocker both
extracellularly and extracellularly; in addition, intracellular
magnesium profoundly blocks several cardiac potassium channels
. These changes can combine to impair cardiovascular function
ECG Changes: prolongation of the P-R interval, an increase in
QRS duration, and an increase in Q-T interval.
CARDIOVASCULAR EFFECTS
Complete heart block and cardiac
arrest may occur at a plasma
magnesium concentration above
15 mEq/L.
32.
Moderate hypermagnesemia caninhibit the secretion of parathyroid
hormone, leading to a reduction in the plasma calcium
concentration
However this fall is usually transient and produces no symptoms
HYPOCALCEMIA
33.
DIAGNOSIS
Hypermagnesemia usually resultsfrom a combination of excess
magnesium intake and a coexisting impairment of renal function.
Diagnosis is usually straightforward and involves measuring serum
magnesium levels, as many cases are unsuspected.
If a magnesium level is not immediately available, a clue to the
existence of hypermagnesemia would be the disease context
(preeclampsia, renal failure), the presence of magnesium-containing
preparations, or a decreased anion gap.
34.
MANAGEMENT
Immediate cessation ofMg administration is required. If renal failure
is not evident, dilution by IV fluids followed by Furosemide (40 to 80
milligrams IV) may be indicated. Calcium directly antagonizes the
[Mg2+].
cardiac effects of magnesium because it reverts the calcium channel
blockade provoked by elevated [Mg]. Severe symptomatic
hypermagnesemia can be treated with 10 mL of 10% calcium
chloride IV over 2 to 3 minutes.
Further infusion of 40 to 60 mL during the next 24 hours can be
administered. Patients with renal failure may benefit from dialysis
using a decreased [Mg2+] bath that lowers serum [Mg2+].